Last10K.com

Pardes Biosciences, Inc. (PRDS) SEC Filing 8-K Material Event for the period ending Thursday, August 31, 2023

Pardes Biosciences, Inc.

HISTORY TOOLS
CIK: 1822711 Ticker: PRDS

View differences made from one to another to evaluate Pardes Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pardes Biosciences, Inc..

Continue

Assess how Pardes Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pardes Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Pardes Biosciences, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 3.1: Articles Of Incorporation
Exhibit 3.2: Articles Of Incorporation
Exhibit 99.1: Additional Exhibits
Ticker: PRDS
CIK: 1822711
Form Type: 8-K Corporate News
Accession Number: 0001140361-23-041917
Submitted to the SEC: Thu Aug 31 2023 8:59:52 AM EST
Accepted by the SEC: Thu Aug 31 2023
Period: Thursday, August 31, 2023
Industry: Pharmaceutical Preparations
Events:
  1. Bylaw Change
  2. Change in Assets
  3. Change in Control
  4. Event for Officers
  5. Financial Exhibit
  6. Listing Status
  7. Other Events
  8. Security Holders Change

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/prds/0001140361-23-041917.htm